The DOI matches its Crossref record.
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Abstract
The subunit composition and pharmacological regulation of rat neuronal nicotinic cholinergic receptors were assessed. Specific immunoprecipitation was determined in solubilized rat brain homogenates using [3H]cytisine, a high affinity agonist at nicotinic receptors, in conjunction with polyclonal antisera generated against nonhomologous domains of the various subunits comprising this receptor class. In all brain regions tested, only antisera generated against the alpha 4 and beta 2 subunits were able to immunoprecipitate specifically receptors labeled by [3H]cytisine. Thus, these sera were further characterized in order to validate and optimize their use in the immunoprecipitation protocol. Preincubation of solubilized receptors from rat forebrain with antisera generated against the alpha 2, alpha 3, alpha 5, beta 3, or beta 4 subunits did not decrease the amount of precipitable alpha 4 or beta 2 subunit. On the other hand, when either anti-alpha 4 or anti-beta 2 serum was used to immunoprecipitate solubilized receptors from rat forebrain, the supernatants contained little if any remaining receptors that could be specifically precipitated by either antibody. Because these antisera do not cross-react, the data indicate that alpha 4 and beta 2 subunits are associated with each other in at least one neuronal nicotinic receptor subtype that has high affinity for agonists. Moreover, these results imply that all alpha 4 subunits that are labeled by [3H]cystisine are coupled to beta 2 subunits. We also present evidence that the alpha 4/beta 2 subtype characterized in this report is significantly increased in the cortex of rats chronically treated with nicotine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, nicotine induced increases in nAChR, termed “upregulation”, are conferred by a specific microdomain that is in the β2-subunit 34 and thus this upregulation is confined to nAChR that contain the β2-subunit4, 19, 31, 35-38.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [19]
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Flores et al., 1992
Citations
Cited by
Sorted by citations
Items 401–500 of 880
Dávila‐García, M. I., Musachio, J. L., & Kellar, K. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01774.x · Cited by 42
Molloy, L., Wonnacott, S., Gallagher, T. C., Brough, P. A., & Livett, B. G. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90153-1 · Cited by 42
Study of the calcium dynamics of the human α4β2, α3β4 and α1β1γδ nicotinic acetylcholine receptors
Michelmore, S., Croskery, K., Nozulak, J., Hoyer, D., Longato, R., Weber, A., Bouhelal, R., & Feuerbach, D. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0589-z · Cited by 42
Tizabi, Y., & Perry, D. C. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00379-8 · Cited by 43
Dobelis, P., Marks, M. J., Whiteaker, P., Balogh, S. A., Collins, A. C., & Stitzel, J. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.334 · Cited by 42
Recent developments in neuronal nicotinic acetylcholine receptor antagonists
Dwoskin, L. P., Xu, R., Ayers, J. T., & Crooks, P. A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.10.1561 · Cited by 42
Holladay, M. W., Lebold, S. A., & Lin, N. (1995) · Drug Development Research · doi:10.1002/ddr.430350402 · Cited by 42
Horti, A. G., Koren, A. O., Lee, K. S., Mukhin, A. G., Vaupel, D. B., Kimes, A. S., Stratton, M., & London, E. D. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00086-9 · Cited by 48
Ji, J., Bunnelle, W. H., Anderson, D. J., Faltynek, C. R., Dyhring, T., Ahring, P. K., Rueter, L. E., Curzon, P., Buckley, M. J., Marsh, K. C., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.010 · Cited by 41
Actions of quinolizidine alkaloids on Periplaneta americana nicotinic acetylcholine receptors
Liu, L., Alam, M. S., Hirata, K., Matsuda, K., & Ozoe, Y. (2008) · Pest Management Science · doi:10.1002/ps.1622 · Cited by 41
Butt, C. M., Hutton, S. R., Stitzel, J. A., Balogh, S. A., Owens, J. C., & Collins, A. C. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000067973.41153.bc · Cited by 40
Ribeiro-Carvalho, A., Lima, C. S., Medeiros, A. H., Siqueira, N. R., Filgueiras, C. C., Manhães, A. C., & Abreu-Villaça, Y. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.032 · Cited by 40
Slotkin, T. A., Cousins, M. M., & Seidler, F. J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.009 · Cited by 40
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Gold, A. B., & Lerman, C. E. (2012) · Human Genetics · doi:10.1007/s00439-012-1143-9 · Cited by 41
Avila, A. M., Dávila‐García, M. I., Ascarrunz, V. S., Xiao, Y., & Kellar, K. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.974 · Cited by 40
Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine
Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 42
The cholinergic deficit in Alzheimer's disease: impact on cognition, behaviour and function
Mega, M. S. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001942 · Cited by 41
Nicotinic Agonist Modulation of Neurotransmitter Levels in the Rat Frontoparietal Cortex
Summers, K. L., Kem, W. R., & Giacobini, E. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.74.139 · Cited by 40
Cormier, A., Paas, Y., Zini, R., Tillement, J. P., Lagrue, G., Changeux, J., & Grailhe, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000463 · Cited by 40
Arnerić, S. P., Anderson, D. J., Bannon, A. W., Briggs, C. A., Buccafusco, J. J., Brioni, J. D., Cannon, J. B., Decker, M. W., Donnelly‐Roberts, D. L., Gopalakrishnan, M., et al. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00274.x · Cited by 40
Pandya, A. A., & Yakel, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.004 · Cited by 41
Abreu‐Villaça, Y., de Medeiros, A. H., Lima, C. S., Faria, F. P., Filgueiras, C. C., & Manhães, A. C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.035 · Cited by 40
Nicotine and ethanol interact during adolescence: Effects on the central cholinergic systems
Ribeiro‐Carvalho, A., Lima, C. S., Filgueiras, C. C., Manhães, A. C., & Abreu‐Villaça, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.062 · Cited by 41
Genetic neurological channelopathies
Hanna, M. G. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0178 · Cited by 39
Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications
Tizabi, Y., Copeland, R., Brus, R., & Kostrzewa, R. M. (1999) · Psychopharmacology · doi:10.1007/s002130051078 · Cited by 39
Pluzarev, O., & Pandey, S. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20216 · Cited by 39
Nucleus isthmi enhances calcium influx into optic nerve fiber terminals in Rana pipiens
Dudkin, E. A., & Gruberg, E. R. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02274-1 · Cited by 39
Lu, Y., Marks, M. J., & Collins, A. C. (1999) · PubMed · Cited by 39
Marks, M. J., Pauly, J. R., Grun, E. U., & Collins, A. C. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00027-7 · Cited by 39
Wainer, I. W., Zhang, Y., Xiao, Y., & Kellar, K. J. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00579-9 · Cited by 39
Prenatal exposure to nicotine: effects on prepulse inhibition and central nicotinic receptors.
Popke, E., Tizabi, Y., Rahman, M. A., Nespor, S., & Grunberg, N. (1997) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(97)98985-1 · Cited by 41
Perez, X. A., O’Leary, K. T., Parameswaran, N., McIntosh, J. M., & Quik, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053801 · Cited by 38
Chatterjee, S., Santos, N., Holgate, J. Y., Haass‐Koffler, C. L., Hopf, F. W., Kharazia, V., Lester, H. A., Bonci, A., & Bartlett, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068300 · Cited by 41
5-I A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors
Zwart, R., Broad, L. M., Xi, Q., Lee, M. W., Moroni, M., Bermúdez, I., & Sher, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.077 · Cited by 38
Shacka, J. J., & Robinson, S. E. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00058-3 · Cited by 38
Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37
Self-citationWang, D. X., Booth, H., Lerner‐Marmarosh, N., Osdene, T. S., & Abood, L. G. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199809)45:1 · Cited by 37
Slotkin, T. A., Ryde, I. T., & Seidler, F. J. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.05.007 · Cited by 38
Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37
Francis, M. M., Vazquez, R. W., Papke, R. L., & Oswald, R. E. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.109 · Cited by 35
Nishizaki, T., Nomura, T., Matuoka, T., Kondoh, T., Enikolopo, G., Sumikawa, K., Watabe, S., Shiotani, T., & Yoshii, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00117-0 · Cited by 37
Tohgi, H., Utsugisawa, K., Yoshimura, M., Nagane, Y., & Mihara, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00093-6 · Cited by 37
Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus
Okuda, H., Shioda, S., Nakai, Y., Nakayama, H., Okamoto, M., & Nakashima, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)90147-f · Cited by 37
Slotkin, T. A., Bodwell, B. E., Ryde, I. T., & Seidler, F. J. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.12.009 · Cited by 36
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 36
Stitzel, J. A., Farnham, D. A., & Collins, A. C. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00149-0 · Cited by 36
Xiao, Y., Baydyuk, M., Wang, H. (., Davis, H. E., & Kellar, K. J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.105 · Cited by 36
AL‐SHAMMA, H. A., & Vries, G. J. D. (1996) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199601)29:1 · Cited by 45
McCallum, S. E., Parameswaran, N., Bordia, T., Fan, H., Tyndale, R. F., Langston, J. W., McIntosh, J. M., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03646.x · Cited by 44
Duncan, J. R., Paterson, D. S., & Kinney, H. C. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.09.006 · Cited by 37
Cox, B. C., Marritt, A. M., Perry, D. C., & Kellar, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05282.x · Cited by 43
Liu, J., Mohila, C., Gong, Y., Govindarajan, N., & Onn, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04423.x · Cited by 35
Vincler, M. A., & Eisenach, J. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02546-0 · Cited by 35
Meyer, E. L., Xiao, Y., & Kellar, K. J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12620-x · Cited by 58
Sensitization of cortical acetylcholine release by repeated administration of nicotine in rats
Arnold, M. H., Nelson, C. L., Sarter, M. F., & Bruno, J. P. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1260-6 · Cited by 35
Hussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
Fedorov, N. B., Benson, L. C., Graef, J. D., Lippiello, P. M., & Bencherif, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146910 · Cited by 34
Palmitoylation of Nicotinic Acetylcholine Receptors
Alexander, J. K., Govind, A. P., Drisdel, R. C., Blanton, M., Vallejo, Y. F., Lam, T. T., & Green, W. N. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9246-z · Cited by 33
Everhart, D., Reiller, E., Mirzoian, A., McIntosh, J. M., Malhotra, A., & Luetje, C. W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051656 · Cited by 34
Sótonyi, P. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfh025 · Cited by 34
Belluardo, N., Mudò, G., Blum, M., Cheng, Q., Caniglia, G., Dell’Albani, P., & Fuxé, K. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00266-1 · Cited by 34
Nicotine Preconditioning Antagonizes Activity-dependent Caspase Proteolysis of a Glutamate Receptor
Meyer, E. L., Gahring, L. C., & Rogers, S. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106744200 · Cited by 34
Briggs, C. A., Gubbins, E. J., Marks, M. J., Putman, C. B., Thimmapaya, R., Meyer, M. D., & Surowy, C. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020198 · Cited by 33
Marks, M. J., Meinerz, N. M., Brown, R. W. B., & Collins, A. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.040 · Cited by 33
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Jacobs, I. C., Anderson, D. J., Surowy, C. S., & Puttfarcken, P. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00166-1 · Cited by 33
C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry, J. A., Voutilainen, M., Barik, J., Cassels, B., Iturriaga-Vásquez, P., Bermúdez, I., Durand, C., Dajas, F., & Wonnacott, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.012 · Cited by 33
Dourado, M., & Sargent, P. B. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.3117 · Cited by 33
Fasoli, F., Moretti, M., Zoli, M., Pistillo, F., Crespi, A., Clementi, F., McClure‐Begley, T. D., Marks, M. J., & Gotti, C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.048 · Cited by 34
Wecker, L., Guo, X., Rycerz, A. M., & Edwards, S. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00041.x · Cited by 33
Brainstem Nicotinic Receptor Subtypes That Influence Intragastric and Arterial Blood Pressures
Ferreira, M. A. R., Singh, A., Dretchen, K. L., Kellar, K. J., & Gillis, R. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39061-5 · Cited by 33
Ghasemi, M., & Niktarash, A. H. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0044 · Cited by 33
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Schmidt, H. D., Rupprecht, L. E., & Addy, N. (2018) · Complex Psychiatry · doi:10.1159/000494799 · Cited by 33
Liu, R., Gu, R., Qi, X., Zhang, T., Zhao, Y. D., He, Y., Pei, J.-J., & Guan, Z. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21463 · Cited by 31
Hanganu, I. L., & Luhmann, H. J. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00010.2004 · Cited by 32
Marks, M. J., Whiteaker, P., Grady, S. R., Picciotto, M. R., McIntosh, J. M., & Collins, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00910.x · Cited by 32
Monteggia, L. M., Gopalakrishnan, M., Touma, E., Idler, K. B., Nash, N. R., Arnerić, S. P., Sullivan, J. P., & Giordano, T. (1995) · Gene · doi:10.1016/0378-1119(94)00914-e · Cited by 32
Moen, J. K., & Lee, A. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745783 · Cited by 30
Zwart, R., Strotton, M., Ching, J., Astles, P., & Sher, E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.031 · Cited by 30
Kroker, K. S., Rast, G. F., & Rosenbrock, H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.167 · Cited by 31
Abou-Donia, M. B., Abdel-Rahman, A., Goldstein, L. B., Dechkovskaia, A. M., Shah, D. U., Bullman, S. L., & Khan, W. A. (2003) · Archives of Toxicology · doi:10.1007/s00204-003-0463-x · Cited by 31
Pilarski, J. Q., Wakefield, H. E., Fuglevand, A. J., Levine, R. B., & Fregosi, R. F. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00623.2011 · Cited by 30
Markus, R. P., dos Santos, J. M., Zago, W. M., & Renó, L. A. C. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045625 · Cited by 31
Nicotinic modulation of thalamocortical neurotransmission
Clarke, P. B. S. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45017-6 · Cited by 31
Rasmussen, B. A., & Perry, D. C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.010 · Cited by 32
Mouse strain-specific changes in nicotinic receptor expression with age
Gahring, L. C., Persiyanov, K., & Rogers, S. W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.005 · Cited by 31
COURT, J. A., Perry, E. K., Spurden, D., Lloyd, S. R., Gillespie, J., Whiting, P. J., & Barlow, R. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91721-3 · Cited by 31
Kawai, Y., & Senba, E. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960923)373:3 · Cited by 88
Stimulation of the α4β2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice
Wildeboer, K. M., & Stevens, K. E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.007 · Cited by 30
Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism
Dubroff, J. G., Doot, R. K., Falcone, M., Schnoll, R. A., Ray, R., Tyndale, R. F., Brody, A. L., Hou, C., Schmitz, A. M. T., & Lerman, C. E. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.155002 · Cited by 31
Slotkin, T. A., Bodwell, B. E., Ryde, I. T., Levin, E. D., & Seidler, F. J. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11451 · Cited by 30
Zhang, J., & Steinbach, J. H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03733-2 · Cited by 30
Is Binding to Nicotinic Acetylcholine and Dopamine Receptors Related to Working Memory in Rats?
Levin, E. D., Torry, D. J., Christopher, N. C., Yu, X., Einstein, G., & Schwartz‐Bloom, R. D. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00009-9 · Cited by 30
Effects of serotonin depletion on local interneurons in the developing olfactory pathway of lobsters
Benton, J. L., & Beltz, B. S. (2001) · Journal of Neurobiology · doi:10.1002/1097-4695(20010215)46:3 · Cited by 38
Sihver, W., Fasth, K., Ögren, M., Lundqvist, H., Bergström, M., Watanabe, Y., Långström, B., & Nordberg, A. K. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00034-7 · Cited by 30
Pollock, V. V., Pastoor, T. E., & Wecker, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04853.x · Cited by 29
Hosur, V., Leppanen, S., Taha, A. A., & Loring, R. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06373.x · Cited by 29
Nowakowska, E., Kus, K., Florek, E., Czubak, A., & Jodynis‐Liebert, J. (2006) · Human & Experimental Toxicology · doi:10.1191/0960327106ht611oa · Cited by 29
Morgenstern, N. A., Isidro, A. F., Israely, I., & Costa, R. M. (2022) · Science Advances · doi:10.1126/sciadv.abh4315 · Cited by 30
Tracy, H. A., Wayner, M. J., & Armstrong, D. L. (1999) · Alcohol · doi:10.1016/s0741-8329(98)00074-3 · Cited by 29
Metadata
- Authors
- Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University Medical Center (US)
- University of Colorado Denver (US)
- Georgetown University (US)
- ORCID
- Kellar, K J
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 41
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2116249462
- Cited by
- 880
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 18 · 2015: 25 · 2014: 25 · 2013: 22 · 2012: 21
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01ag009884-05, 5r01da006486-10, 5r01ns011549-24)
- National Institute on Aging (AG 09884)
- National Institute on Drug Abuse (DA-06486)
- National Institute of Neurological Disorders and Stroke (NS11549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor subunit composition, chronic nicotine treatment, receptor up-regulation, rat cortex, forebrain, neuronal nicotinic receptors
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Antibodies, Azocines, Brain, Kinetics, Male, Nicotine, Precipitin Tests, Quinolizines, Rats, Inbred Strains, Receptors, Nicotinic, Time Factors, Tritium, Up-Regulation, Macromolecular Substances, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review